{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:27:23Z","timestamp":1778034443003,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03713-0","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T09:36:28Z","timestamp":1755509788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ganglion cell function loss in extensive macular atrophy with pseudodrusen"],"prefix":"10.1007","volume":"45","author":[{"given":"Sung Eun Song","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andressa Zanini Fantato","family":"Quercia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glaycielli Pereira Santos Mandaro","family":"de Assis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena Leal","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Yuri","family":"Sacai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"4","key":"3713_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ajo.2008.10.022","volume":"147","author":"CP Hamel","year":"2009","unstructured":"Hamel CP, Meunier I, Arndt C et al (2009) Extensive macular atrophy with pseudodrusen-like appearance: a new clinical entity. Am J Ophthalmol 147(4):609\u2013620. https:\/\/doi.org\/10.1016\/j.ajo.2008.10.022","journal-title":"Am J Ophthalmol"},{"key":"3713_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-024-06600-z","author":"MM Carl\u00e0","year":"2024","unstructured":"Carl\u00e0 MM, Giannuzzi F, Boselli F et al (2024) Extensive macular atrophy with pseudodrusen-like appearance: comprehensive review of the literature. Graefes Arch Clin Exp Ophthalmol. https:\/\/doi.org\/10.1007\/s00417-024-06600-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"3713_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10633-023-09941-y","volume":"147","author":"SES Watanabe","year":"2023","unstructured":"Watanabe SES, Quercia AZF, Sacai PY (2023) Electrophysiological findings in extensive macular atrophy with pseudodrusen. Doc Ophthalmol 147(2):121\u2013130. https:\/\/doi.org\/10.1007\/s10633-023-09941-y","journal-title":"Doc Ophthalmol"},{"key":"3713_CR4","doi-asserted-by":"publisher","first-page":"101320","DOI":"10.1016\/j.preteyeres.2024.101320","volume":"104","author":"A Antropoli","year":"2025","unstructured":"Antropoli A, Bianco L, Romano F et al (2025) Extensive macular atrophy with pseudodrusen-like appearance (EMAP) clinical characteristics, diagnostic criteria, and insights from allied inherited retinal diseases and age-related macular degeneration. Prog Retin Eye Res 104:101320. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101320","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"3713_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.ophtha.2024.04.001","volume":"131","author":"A Antropoli","year":"2024","unstructured":"Antropoli A, Bianco L, Condroyer C et al (2024) Extensive Macular Atrophy with Pseudodrusen-like appearance: progression kinetics and late-stage findings. Ophthalmology 131(10):1175\u20131184. https:\/\/doi.org\/10.1016\/j.ophtha.2024.04.001","journal-title":"Ophthalmology"},{"issue":"53","key":"3713_CR6","doi-asserted-by":"publisher","first-page":"104550","DOI":"10.1016\/j.pdpdt.2025.104550","volume":"5","author":"R Aydin","year":"2025","unstructured":"Aydin R, Ozbek M, Artunay O (2025) Multimodal imaging for evaluation and quantification of atrophy progression in extensive macular atrophy with pseudodrusen. Photodiagnosis Photodyn Ther 5(53):104550. https:\/\/doi.org\/10.1016\/j.pdpdt.2025.104550","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"3","key":"3713_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/IAE.0000000000003683","volume":"43","author":"F Romano","year":"2023","unstructured":"Romano F, Cozzi M, Monteduro D et al (2023) Natural course and classification of extensive macular atrophy with pseudodrusen-like appearance. Retina 43(3):402\u2013411. https:\/\/doi.org\/10.1097\/IAE.0000000000003683","journal-title":"Retina"},{"issue":"2","key":"3713_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10633-019-09723-5","volume":"140","author":"G Ortiz","year":"2020","unstructured":"Ortiz G, Drucker D, Hyde C et al (2020) The photopic negative response of the light-adapted 3.0 ERG in clinical settings. Doc Ophthalmol 140(2):115\u2013128. https:\/\/doi.org\/10.1007\/s10633-019-09723-5","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"3713_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch DL, Marmor MF, Brigell MG et al (2015) ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1\u201312. https:\/\/doi.org\/10.1007\/s10633-014-9473-7","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"3713_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","volume":"144","author":"AG Robson","year":"2022","unstructured":"Robson AG, Frishman LJ, Grigg J et al (2022) ISCEV standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144(3):165\u2013177. https:\/\/doi.org\/10.1007\/s10633-022-09872-0","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"3713_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10633-018-9638-x","volume":"136","author":"LJ Frishman","year":"2018","unstructured":"Frishman LJ, Sustar M, Kremers J et al (2018) ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram. Doc Ophthalmol 136(3):207\u2013211. https:\/\/doi.org\/10.1007\/s10633-018-9638-x","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"3713_CR12","doi-asserted-by":"publisher","first-page":"6840","DOI":"10.1038\/s41598-018-25003-9","volume":"8","author":"A Douillard","year":"2018","unstructured":"Douillard A, Picot MC, Delcourt C et al (2018) Dietary, environmental, and genetic risk factors of extensive macular atrophy with pseudodrusen, a severe bilateral macular atrophy of middle-aged patients. Sci Rep 8(1):6840. https:\/\/doi.org\/10.1038\/s41598-018-25003-9","journal-title":"Sci Rep"},{"issue":"7","key":"3713_CR13","first-page":"1533","volume":"65","author":"L Bianco","year":"2024","unstructured":"Bianco L, Antropoli A, Benadji A et al (2024) Full-field electroretinogram in extensive macular atrophy with pseudodrusen-like deposits (EMAP). Invest Ophthalmol Vis Sci 65(7):1533","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"3713_CR14","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.3.6.1","volume":"3","author":"J Tang","year":"2014","unstructured":"Tang J, Edwards T, Crowston JG et al (2014) The test-retest reliability of the photopic negative response (PhNR). Transl Vis Sci Technol 3(6):1. https:\/\/doi.org\/10.1167\/tvst.3.6.1","journal-title":"Transl Vis Sci Technol"},{"key":"3713_CR15","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s10792-020-01515-0","volume":"40","author":"M Prencipe","year":"2020","unstructured":"Prencipe M, Perossini T, Brancoli G et al (2020) The photopic negative response (PhNR): measurement approaches and utility in glaucoma. Int Ophthalmol 40:3565\u20133576. https:\/\/doi.org\/10.1007\/s10792-020-01515-0","journal-title":"Int Ophthalmol"},{"key":"3713_CR16","doi-asserted-by":"publisher","first-page":"628014","DOI":"10.3389\/fneur.2020.628014","volume":"11","author":"GIS Botelho","year":"2021","unstructured":"Botelho GIS, Salom\u00e3o SR, Tengan CH et al (2021) Impaired ganglion cell function objectively assessed by the photopic negative response in affected and asymptomatic members from Brazilian families with Leber\u2019s hereditary optic neuropathy. Front Neurol 11:628014. https:\/\/doi.org\/10.3389\/fneur.2020.628014","journal-title":"Front Neurol"},{"issue":"7","key":"3713_CR17","doi-asserted-by":"publisher","first-page":"e40616","DOI":"10.1371\/journal.pone.0040616","volume":"7","author":"SC Joachim","year":"2012","unstructured":"Joachim SC, Gramlich OW, Laspas P et al (2012) Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens. PLoS ONE 7(7):e40616. https:\/\/doi.org\/10.1371\/journal.pone.0040616","journal-title":"PLoS ONE"},{"issue":"7","key":"3713_CR18","first-page":"1657","volume":"41","author":"I Maruyama","year":"2000","unstructured":"Maruyama I, Ohguro H, Ikeda Y (2000) Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients. Invest Ophthalmol Vis Sci 41(7):1657\u20131665","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"3713_CR19","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.ophtha.2016.05.018","volume":"123","author":"A Douillard","year":"2016","unstructured":"Douillard A, Picot MC, Delcourt C et al (2016) Clinical characteristics and risk factors of extensive macular atrophy with pseudodrusen: the EMAP case-control national clinical trial. Ophthalmology 123(9):1865\u20131873. https:\/\/doi.org\/10.1016\/j.ophtha.2016.05.018","journal-title":"Ophthalmology"},{"issue":"3","key":"3713_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1159\/000526970","volume":"13","author":"S Sato","year":"2022","unstructured":"Sato S, Morimoto T, Fujikado T et al (2022) Extensive macular atrophy with pseudodrusen in a Japanese patient evaluated by wide-field OCTA. Case Rep Ophthalmol 13(3):847\u2013854. https:\/\/doi.org\/10.1159\/000526970","journal-title":"Case Rep Ophthalmol"},{"key":"3713_CR21","doi-asserted-by":"publisher","unstructured":"GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study (2021) Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health 9(2):e144\u2013e160. https:\/\/doi.org\/10.1016\/S2214-109X(20)30489-7. Epub 2020 Dec 1. Erratum in: Lancet Glob Health 9(4):e408. https:\/\/doi.org\/10.1016\/S2214-109X(21)00050-4","DOI":"10.1016\/S2214-109X(20)30489-7"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03713-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03713-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03713-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:03:36Z","timestamp":1766167416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03713-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3713"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03713-0","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Hospital IGESP\u2014Instituto de Gastroenterologia de S\u00e3o Paulo S\/A\/Centro M\u00e9dico e Cir\u00fargico (March 15, 2022; No. 5.292.837).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"338"}}